Annual Shareholders Equity
$195.43 M
+$589.00 K+0.30%
December 31, 2023
Summary
- As of February 12, 2025, COLL annual stockholders equity is $195.43 million, with the most recent change of +$589.00 thousand (+0.30%) on December 31, 2023.
- During the last 3 years, COLL annual shareholders equity has risen by +$9.40 million (+5.05%).
- COLL annual shareholders equity is now -3.69% below its all-time high of $202.93 million, reached on December 31, 2021.
Performance
COLL Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$234.28 M
+$17.70 M+8.17%
September 30, 2024
Summary
- As of February 12, 2025, COLL quarterly stockholders equity is $234.28 million, with the most recent change of +$17.70 million (+8.17%) on September 30, 2024.
- Over the past year, COLL quarterly shareholders equity has increased by +$55.41 million (+30.98%).
- COLL quarterly shareholders equity is now -7.42% below its all-time high of $253.07 million, reached on June 30, 2021.
Performance
COLL Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
COLL Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +0.3% | +31.0% |
3 y3 years | +5.0% | +31.0% |
5 y5 years | +113.4% | +31.0% |
COLL Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -3.7% | +0.3% | at high | +31.0% |
5 y | 5-year | -3.7% | +123.5% | -7.4% | +168.0% |
alltime | all time | -3.7% | +1696.5% | -7.4% | +2013.9% |
Collegium Pharmaceutical Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $234.28 M(+8.2%) |
Jun 2024 | - | $216.58 M(-2.5%) |
Mar 2024 | - | $222.17 M(+13.7%) |
Dec 2023 | $195.43 M(+0.3%) | $195.43 M(+9.3%) |
Sep 2023 | - | $178.87 M(-10.9%) |
Jun 2023 | - | $200.81 M(+11.7%) |
Mar 2023 | - | $179.73 M(-7.8%) |
Dec 2022 | $194.84 M(-4.0%) | $194.84 M(-1.2%) |
Sep 2022 | - | $197.19 M(-0.2%) |
Jun 2022 | - | $197.61 M(+0.8%) |
Mar 2022 | - | $196.08 M(-3.4%) |
Dec 2021 | $202.93 M(+9.1%) | $202.93 M(-19.2%) |
Sep 2021 | - | $251.09 M(-0.8%) |
Jun 2021 | - | $253.07 M(+48.8%) |
Mar 2021 | - | $170.03 M(-8.6%) |
Dec 2020 | $186.03 M(+112.8%) | $186.03 M(+7.7%) |
Sep 2020 | - | $172.69 M(+10.9%) |
Jun 2020 | - | $155.77 M(+10.4%) |
Mar 2020 | - | $141.06 M(+61.3%) |
Dec 2019 | $87.43 M | $87.43 M(+3.8%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2019 | - | $84.26 M(-1.8%) |
Jun 2019 | - | $85.82 M(-0.6%) |
Mar 2019 | - | $86.35 M(-5.7%) |
Dec 2018 | $91.58 M(-12.0%) | $91.58 M(+29.4%) |
Sep 2018 | - | $70.78 M(-14.4%) |
Jun 2018 | - | $82.68 M(-9.0%) |
Mar 2018 | - | $90.82 M(-12.7%) |
Dec 2017 | $104.08 M(-22.9%) | $104.08 M(+8.1%) |
Sep 2017 | - | $96.27 M(+0.8%) |
Jun 2017 | - | $95.51 M(-16.5%) |
Mar 2017 | - | $114.37 M(-15.2%) |
Dec 2016 | $134.91 M(+58.6%) | $134.91 M(+81.5%) |
Sep 2016 | - | $74.33 M(-24.7%) |
Jun 2016 | - | $98.66 M(-19.0%) |
Mar 2016 | - | $121.74 M(+43.1%) |
Dec 2015 | $85.07 M(-795.0%) | $85.07 M(-9.1%) |
Sep 2015 | - | $93.56 M(-8.6%) |
Jun 2015 | - | $102.42 M(+197.3%) |
Mar 2015 | - | $34.45 M(-381.4%) |
Dec 2014 | -$12.24 M(-319.3%) | -$12.24 M |
Dec 2013 | $5.58 M | - |
FAQ
- What is Collegium Pharmaceutical annual stockholders equity?
- What is the all time high annual shareholders equity for Collegium Pharmaceutical?
- What is Collegium Pharmaceutical annual shareholders equity year-on-year change?
- What is Collegium Pharmaceutical quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Collegium Pharmaceutical?
- What is Collegium Pharmaceutical quarterly shareholders equity year-on-year change?
What is Collegium Pharmaceutical annual stockholders equity?
The current annual shareholders equity of COLL is $195.43 M
What is the all time high annual shareholders equity for Collegium Pharmaceutical?
Collegium Pharmaceutical all-time high annual stockholders equity is $202.93 M
What is Collegium Pharmaceutical annual shareholders equity year-on-year change?
Over the past year, COLL annual stockholders equity has changed by +$589.00 K (+0.30%)
What is Collegium Pharmaceutical quarterly stockholders equity?
The current quarterly shareholders equity of COLL is $234.28 M
What is the all time high quarterly shareholders equity for Collegium Pharmaceutical?
Collegium Pharmaceutical all-time high quarterly stockholders equity is $253.07 M
What is Collegium Pharmaceutical quarterly shareholders equity year-on-year change?
Over the past year, COLL quarterly stockholders equity has changed by +$55.41 M (+30.98%)